Robert L Tiso, MD | |
5496 East Taft Road, North Syracuse, NY 13212 | |
(315) 552-6700 | |
(315) 552-6701 |
Full Name | Robert L Tiso |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 38 Years |
Location | 5496 East Taft Road, North Syracuse, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942295092 | NPI | - | NPPES |
01196510 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 171318 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New York Anesthesiology Medical Specialties Pc | 3375535396 | 29 |
News Archive
Junk food is a burgeoning problem for modern society: we literally have too much on our plate. Fatty and unhealthy foods are especially popular with young children and adolescents. They are often the cheapest and most convenient eating option.
Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
Patients suffering from conditions such as stroke, blindness, deafness, incontinence, glaucoma or hydrocephalus will be the first to benefit from a range of new technologies and implantable medical devices developed by a pioneering European consortium of researchers, surgeons and technology companies.
"Dual key" activation, in which two people must act in concert to launch a weapon, is often installed to safeguard highly destructive arms.
› Verified 8 days ago
Entity Name | New York Anesthesiology Medical Specialties Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841285996 PECOS PAC ID: 3375535396 Enrollment ID: O20040331000822 |
News Archive
Junk food is a burgeoning problem for modern society: we literally have too much on our plate. Fatty and unhealthy foods are especially popular with young children and adolescents. They are often the cheapest and most convenient eating option.
Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
Patients suffering from conditions such as stroke, blindness, deafness, incontinence, glaucoma or hydrocephalus will be the first to benefit from a range of new technologies and implantable medical devices developed by a pioneering European consortium of researchers, surgeons and technology companies.
"Dual key" activation, in which two people must act in concert to launch a weapon, is often installed to safeguard highly destructive arms.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Robert L Tiso, MD Po Box 510, Syracuse, NY 13214-0510 Ph: (315) 703-3484 | Robert L Tiso, MD 5496 East Taft Road, North Syracuse, NY 13212 Ph: (315) 552-6700 |
News Archive
Junk food is a burgeoning problem for modern society: we literally have too much on our plate. Fatty and unhealthy foods are especially popular with young children and adolescents. They are often the cheapest and most convenient eating option.
Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, has announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies.
Patients suffering from conditions such as stroke, blindness, deafness, incontinence, glaucoma or hydrocephalus will be the first to benefit from a range of new technologies and implantable medical devices developed by a pioneering European consortium of researchers, surgeons and technology companies.
"Dual key" activation, in which two people must act in concert to launch a weapon, is often installed to safeguard highly destructive arms.
› Verified 8 days ago
Joseph A Catania, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5496 East Taft Road, North Syracuse, NY 13212 Phone: 315-552-6700 Fax: 315-552-6701 |